Almost every corner of the healthcare market was affected by COVID-19 in some way. However, deal data shows that PE investors were undeterred in 2020 and 2021, as consolidation efforts, demographic shifts, and heightened demand for orthopedic care outweighed broader market uncertainties, according to a report from Vector Medical Group and Epstein, Becker Green.
Buyouts remain an integral part of the landscape, though nonmajority growth transactions have become more common in recent years. Add-on acquisitions have also lifted deal volume, as PE sponsors grow their platforms into regional and national players via smaller acquisitions. Read more.
